Search Results - "NIXON, F"

Refine Results
  1. 1

    Sphingolipids in inflammation: pathological implications and potential therapeutic targets by Nixon, Graeme F.

    Published in British journal of pharmacology (01-10-2009)
    “…Sphingolipids are formed via the metabolism of sphingomyelin, a constituent of the plasma membrane, or by de novo synthesis. Enzymatic pathways result in the…”
    Get full text
    Journal Article
  2. 2

    Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development by Leeansyah, Edwin, Loh, Liyen, Nixon, Douglas F., Sandberg, Johan K.

    Published in Nature communications (01-01-2014)
    “…Innate-like, evolutionarily conserved MR1-restricted mucosa-associated invariant T (MAIT) cells represent a large antimicrobial T-cell subset in humans. Here,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity by Ndhlovu, Lishomwa C., Lopez-Vergès, Sandra, Barbour, Jason D., Jones, R. Brad, Jha, Aashish R., Long, Brian R., Schoeffler, Eric C., Fujita, Tsuyoshi, Nixon, Douglas F., Lanier, Lewis L.

    Published in Blood (19-04-2012)
    “…Natural killer (NK) cells are innate lymphocytes that play an important role against viral infections and cancer. This effect is achieved through a complex…”
    Get full text
    Journal Article
  6. 6

    Heterologous vaccine interventions: boosting immunity against future pandemics by Marín-Hernández, Daniela, Nixon, Douglas F., Hupert, Nathaniel

    Published in Molecular medicine (Cambridge, Mass.) (31-05-2021)
    “…While vaccines traditionally have been designed and used for protection against infection or disease caused by one specific pathogen, there are known…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Allatostatin C modulates nociception and immunity in Drosophila by Bachtel, Nathaniel D., Hovsepian, Gary A., Nixon, Douglas F., Eleftherianos, Ioannis

    Published in Scientific reports (14-05-2018)
    “…Bacterial induced inflammatory responses cause pain through direct activation of nociceptive neurons, and the ablation of these neurons leads to increased…”
    Get full text
    Journal Article
  9. 9

    T Cell Immunity in Acute HIV-1 Infection by Streeck, Hendrik, Nixon, Douglas F.

    Published in The Journal of infectious diseases (15-10-2010)
    “…Exceedingly high viral loads and rapid loss of CD4+ T cells in all tissue compartments are a hallmark of acute human immunodeficiency virus type 1 (HIV-1)…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Ribosomal profiling of human endogenous retroviruses in healthy tissues by Dopkins, Nicholas, Singh, Bhavya, Michael, Stephanie, Zhang, Panpan, Marston, Jez L, Fei, Tongyi, Singh, Manvendra, Feschotte, Cedric, Collins, Nicholas, Bendall, Matthew L, Nixon, Douglas F

    Published in BMC genomics (02-01-2024)
    “…Human endogenous retroviruses (HERVs) are the germline embedded proviral fragments of ancient retroviral infections that make up roughly 8% of the human…”
    Get full text
    Journal Article
  11. 11

    Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target by Curty, Gislaine, Marston, Jez L, de Mulder Rougvie, Miguel, Leal, Fabio E, Nixon, Douglas F, Soares, Marcelo A

    Published in Viruses (06-07-2020)
    “…In diseases where epigenetic mechanisms are changed, such as cancer, many genes show altered gene expression and inhibited genes become activated. Human…”
    Get full text
    Journal Article
  12. 12

    Extreme immunotherapy: emergency immunology to defeat pandemics by Nixon, Douglas F, Marín-Hernández, Daniela, Hupert, Nathaniel

    Published in Molecular medicine (Cambridge, Mass.) (16-09-2021)
    “…The ongoing global COVID-19 pandemic has thrown into sharp relief the gap between modern biology's ability to investigate and respond to a novel pathogen and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany by Marín-Hernández, Daniela, Nixon, Douglas F., Hupert, Nathaniel

    Published in Human vaccines & immunotherapeutics (03-08-2021)
    “…Bacillus Calmette-Guérin (BCG) vaccine is known to have "bystander benefits" in protecting against heterologous infections; interim analysis of the "ACTIVATE"…”
    Get full text
    Journal Article
  15. 15
  16. 16

    HIV-1 replication and latency are balanced by mTOR-driven cell metabolism by Crater, Jacqueline M, Nixon, Douglas F, Furler O'Brien, Robert L

    “…Human Immunodeficiency virus type 1 (HIV-1) relies on host cell metabolism for all aspects of viral replication. Efficient HIV-1 entry, reverse transcription,…”
    Get full text
    Journal Article
  17. 17

    Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens by AANDAHL, Einar M, MICHAËLSSON, Jakob, MORETTO, Walter J, HECHT, Frederick M, NIXON, Douglas F

    Published in Journal of Virology (01-03-2004)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  18. 18

    Enriched environment and stress exposure influence splenic B lymphocyte composition by Gurfein, Blake T, Hasdemir, Burcu, Milush, Jeffrey M, Touma, Chadi, Palme, Rupert, Nixon, Douglas F, Darcel, Nicholas, Hecht, Frederick M, Bhargava, Aditi

    Published in PloS one (12-07-2017)
    “…Prolonged chronic stress has deleterious effects on immune function and is associated with numerous negative health outcomes. The spleen harbors one-fourth of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression by Curty, Gislaine, Iniguez, Luis P, Soares, Marcelo A, Nixon, Douglas F, de Mulder Rougvie, Miguel

    Published in Viruses (20-07-2022)
    “…Many drugs have been evaluated to reactivate HIV-1 from cellular reservoirs, but the off-target effects of these latency reversal agents (LRA) remain poorly…”
    Get full text
    Journal Article